GenMark Diagnostics Inc (GNMK)

NASDAQ
24.04
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    24.03 - 24.06

GNMK Overview

Prev. Close
24.04
Day's Range
24.03-24.06
Revenue
132.82M
Open
24.04
52 wk Range
10.6-24.25
EPS
-0.28
Volume
0
Market Cap
1.77B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
452,351
P/E Ratio
-
Beta
3.02
1-Year Change
70.01%
Shares Outstanding
73,595,021
Next Earnings Date
-
What is your sentiment on GenMark Diagnostics Inc?
or
Market is currently closed. Voting is open during market hours.

GenMark Diagnostics Inc Company Profile

GenMark Diagnostics, Inc. designs and manufactures multiplex molecular diagnostic solutions to enhance patient care, improve quality metrics, and reduce the total cost-of-care for laboratory professionals, healthcare providers, and customers in the United States and internationally. It offers ePlex systems to streamline the diagnostic workflow from physician order entry to the release of the final report, automate and accelerate order entry and results reporting, notify practitioners that test results are available, enable operation on every shift, minimize system downtime and ensure patients and physicians have access to rapid test results, and reduce avoidable medical errors; ePlex software to support the needs of laboratory and healthcare systems, streamline tasks across the diagnostic process from order-to-report, improve productivity at every level, improve order-to-report turnaround time, reduce labor costs, and eliminate potential transcription errors with bi-directional LIS capabilities; XT-8 systems for processing multiple tests; ePlex panels that include respiratory pathogen and blood culture identification (BCID) Panels to identify the viral and bacterial organisms associated with upper respiratory infection, provide broad coverage of organisms that can lead to sepsis along with the resistance genes, and aid clinicians in the identification of bacterial and fungal organisms; and XT-8 panels to provide sensitive and specific respiratory virus detection with an optimized workflow to maximize laboratory efficiency. The company serves customers through distributors. GenMark Diagnostics, Inc. was formerly known as Osmetech plc and changed its name to GenMark Diagnostics, Inc. in June 2010. The company was incorporated in 2010 and is based in Carlsbad, California. As of April 21, 2021, GenMark Diagnostics, Inc. operates as a subsidiary of Roche Holding AG.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary
  • Roche is buying out.
    0
    • is this max point of increase
      0
    • Dong ThreeThousand usually, when a buyout happens, the increase remains quite stable throughout the day. Cheers.
      0
  • anyone know what will happen now
    0
    • What happened?!!!!! Why???
      0
      • Frankfurt is up 15% for this stock!!
        0
        • I would imagine this gets higher than 12.33 in a week or two
          0
          • I guess nobody really cares about a brand new covid test. Not the catalyst lift i was hoping for. Sigh.
            0
            • Why the big down?
              0
              • Buy now?
                0
                • I hope you didn't do it in pre-market.
                  0
              • to late to buy?
                0
                • too late to buy?
                  0
                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.